News

West Virginia Prescription Monitoring Program

West Virginia Prescription Monitoring Program – Gabapentin Reporting Requirements

As of July 7, 2017, pharmacies in West Virginia are required to report Gabapentin as a Drug of Concern to the state’s Controlled Substance Monitoring Program (CSMP).

The state also changed some ASAP field requirements on July 7, with more changes anticipated on August 15. These are noted in the state’s guide Changes to Data Submission.

Assistance and Support: For additional background, review the state’s guide Changes to Data Submission. For technical support, visit vendor RxDataTrack’s Controlled Substance Automated Prescription Program (CSAPP), email support@rxdatatrack.com or call 681.265.0340. If you have policy questions, visit the West Virginia Board of Pharmacy or call 304.558.0558.

Share this post

Leave a comment



Please enter the word you see in the image below:


Real Time Web Analytics